Not provided
Not provided
Not provided
Not provided
Not provided
Study determined not to be feasible to continue.
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Wound Care Technologies, Inc. | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Fasciotomy wounds are rarely able to be closed at the time of index surgery. They often require multiple returns to surgery for closure, and occasionally require skin grafting (i.e. they are never completely closed). We are interested in seeing whether this device, which provides constant and gradual tension on the wound, may allow for rapid wound closure in a safe fashion, perhaps even precluding a return trip to surgery.
Null hypothesis #1: The Dermaclose Wound Management System (Woundcare Technologies Inc, Chanhassen, Minnesota) will not result in closure of fasciotomy wounds more rapidly than standard vessel loop techniques.
Null hypothesis #2: The Dermaclose Wound Management System will not reduce the number of return trips to the operating room for surgical procedures related to closure or skin grafting of fasciotomy wounds.
After IRB approval, all patients meeting inclusion criteria and requiring fasciotomy of the arms, legs, or pelvis will be consented for participation in the research study. Patients will either have their fasciotomy wounds closed through application of the Dermaclose device, as per the manufacturer's instructions, or through application of vessel loops with staples in a "shoestring technique" as described in the literature (1). Choice of wound closure technique will be at surgeon discretion. All patients will undergo application of a vacuum-assisted wound closure device (Wound VAC, Active Healing Solutions Inc, San Antonio, TX), which is standard of care for temporary coverage of open wounds (2, 3). Patients will be returned to the operating room every 2-3 days until wound closure or skin grafting has been accomplished. If skin closure is not accomplished in the operating room, but occurs prior to return trip to the operating room, then definitive suture closure of the wound will be performed under local anaesthetic, followed by removal of the Dermaclose device or of the vessel loop with staple shoestring. Decisions regarding wound closure or skin grafting in the operating room will be left to the judgment of the attending surgeon.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Vessel Loop fasciotomy closure | Active Comparator | Fasciotomy closure using vessel loops and staples. |
|
| DermaClose fasciotomy closure | Experimental | Fasciotomy closure via DermaClose device |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| DermaClose fasciotomy closure | Device | The DermaClose device provides continuous expanding of the skin around the wound until it has stretched enough to allow the skin edges to be sutured closed. |
| Measure | Description | Time Frame |
|---|---|---|
| Performance of DermaClose System in Treatment of Fasciotomy Wounds | Days to wound closure; number and types of procedures required for wound closure; infection requiring reoperation; wound dehiscence requiring reoperation | One year |
| Measure | Description | Time Frame |
|---|---|---|
| Pain | Visual Analog Pain Scale (VAS) during initial hospitalization and at 2 weeks, 6 weeks, 3 months, 6 months, and 12 months | One Year |
| Quality of Life | Quality of Life measured by the SF-12 version 1 at 2 weeks, 6 weeks, 3 months, 6 months, and 12 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gregory J Della Rocca, MD. PhD | University of Missouri-Columbia | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Missouri Hospital and Clinics | Columbia | Missouri | 65212 | United States |
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Vessel Loop Fasciotomy Closure | Fasciotomy closure using vessel loops and staples. Vessel loop: Vessel loops and staples for fasciotomy closure |
| FG001 | DermaClose Fasciotomy Closure | Fasciotomy closure via DermaClose device DermaClose Continuous External Tissue Expander: The DermaClose device provides continuous expanding of the skin around the wound until it has stretched enough to allow the skin edges to be sutured closed. |
| Title | Milestones | Reasons Not Completed | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Vessel Loop Fasciotomy Closure | Fasciotomy closure using vessel loops and staples. Vessel loop: Vessel loops and staples for fasciotomy closure |
| BG001 | DermaClose Fasciotomy Closure |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Performance of DermaClose System in Treatment of Fasciotomy Wounds | Days to wound closure; number and types of procedures required for wound closure; infection requiring reoperation; wound dehiscence requiring reoperation | Too low of an enrollment volume to analyze | Posted | One year |
|
Not provided
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Vessel Loop Fasciotomy Closure | Fasciotomy closure using vessel loops and staples. Vessel loop: Vessel loops and staples for fasciotomy closure |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Gregory J. Della Rocca, MD, PhD, FACS | University of Missouri, Department of Orthopaedic Surgery | 573-882-6562 | dellaroccag@health.missouri.edu |
Not provided
| ID | Term |
|---|---|
| D014947 | Wounds and Injuries |
| D003161 | Compartment Syndromes |
| ID | Term |
|---|---|
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Vessel loop | Device | Vessel loops and staples for fasciotomy closure |
|
| One Year |
| Cost-to-Benefit Ratio of DermaClose Versus Vessel Loop Fasciotomy Closure | Costs associated with both types of closure (DermaClose and Vessel Loop) including hospital days, number of procedures, procedural and hospital costs including device(s), negative pressure wound therapy costs, and operating room time and associated costs. | One year |
Fasciotomy closure via DermaClose device
DermaClose Continuous External Tissue Expander: The DermaClose device provides continuous expanding of the skin around the wound until it has stretched enough to allow the skin edges to be sutured closed.
| BG002 | Total | Total of all reporting groups |
| Participants |
|
| Sex: Female, Male | Count of Participants | Participants |
|
|
| Secondary | Pain | Visual Analog Pain Scale (VAS) during initial hospitalization and at 2 weeks, 6 weeks, 3 months, 6 months, and 12 months | too low of an enrollment volume to analyze | Posted | One Year |
|
|
| Secondary | Quality of Life | Quality of Life measured by the SF-12 version 1 at 2 weeks, 6 weeks, 3 months, 6 months, and 12 months | This study was terminated before any of this information was collected and analyzed. | Posted | One Year |
|
|
| Secondary | Cost-to-Benefit Ratio of DermaClose Versus Vessel Loop Fasciotomy Closure | Costs associated with both types of closure (DermaClose and Vessel Loop) including hospital days, number of procedures, procedural and hospital costs including device(s), negative pressure wound therapy costs, and operating room time and associated costs. | This study was terminated before this information was collected and analyzed. | Posted | One year |
|
|
| 0 |
| 0 |
| 0 |
| 0 |
| EG001 | DermaClose Fasciotomy Closure | Fasciotomy closure via DermaClose device DermaClose Continuous External Tissue Expander: The DermaClose device provides continuous expanding of the skin around the wound until it has stretched enough to allow the skin edges to be sutured closed. | 0 | 7 | 0 | 7 |
Not provided